These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28449404)

  • 1. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.
    Kesselheim AS; Donneyong M; Dal Pan GJ; Zhou EH; Avorn J; Schneeweiss S; Seeger JD
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):712-721. PubMed ID: 28449404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.
    Kesselheim AS; Sinha MS; Rausch P; Lu Z; Tessema FA; Lappin BM; Zhou EH; Dal Pan GJ; Zwanziger L; Ramanadham A; Loughlin A; Enger C; Avorn J; Campbell EG
    J Law Med Ethics; 2019 Sep; 47(3):430-441. PubMed ID: 31560634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological approaches to evaluate the impact of FDA drug safety communications.
    Kesselheim AS; Campbell EG; Schneeweiss S; Rausch P; Lappin BM; Zhou EH; Seeger JD; Brownstein JS; Woloshin S; Schwartz LM; Toomey T; Dal Pan GJ; Avorn J
    Drug Saf; 2015 Jun; 38(6):565-75. PubMed ID: 25968811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center.
    Gray E; Bradley B
    J Am Pharm Assoc (2003); 2019; 59(4S):S146-S150. PubMed ID: 31248847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis.
    Woloshin S; Schwartz LM; Dejene S; Rausch P; Dal Pan GJ; Zhou EH; Kesselheim AS
    J Health Commun; 2017 May; 22(5):365-372. PubMed ID: 28339323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings.
    Kim HM; Gerlach LB; Yosef M; Stano C; Conroy DA; Valenstein M; Pfeiffer PN; Sales AE; Zivin K
    J Clin Sleep Med; 2018 Jul; 14(7):1135-1141. PubMed ID: 29991420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trend changes of national zolpidem users and exposure cases after FDA drug safety communications.
    Zhou EH; Feng Z; Pinnow E; Lee J; Bak D; Ready T; Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1551-1559. PubMed ID: 34382718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward evidence-based prescribing at end of life: a comparative review of temazepam and zolpidem for the treatment of insomnia.
    Bain KT; Weschules DJ; Knowlton CH; Gallagher R
    Am J Hosp Palliat Care; 2003; 20(5):382-8. PubMed ID: 14529041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in prescribing of zolpidem in the Veterans Health Administration.
    Jasuja GK; Reisman JI; Weiner RS; Christopher ML; Rose AJ
    Am J Manag Care; 2019 Mar; 25(3):e58-e65. PubMed ID: 30875172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study.
    Kesselheim AS; McGraw SA; Dejene SZ; Rausch P; Dal Pan GJ; Lappin BM; Zhou EH; Avorn J; Campbell EG
    Drug Saf; 2017 Jun; 40(6):531-542. PubMed ID: 28247279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis.
    Sinha MS; Freifeld CC; Brownstein JS; Donneyong MM; Rausch P; Lappin BM; Zhou EH; Dal Pan GJ; Pawar AM; Hwang TJ; Avorn J; Kesselheim AS
    JMIR Public Health Surveill; 2018 Jan; 4(1):e1. PubMed ID: 29305342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications.
    Geller AI; Zhou EH; Budnitz DS; Lovegrove MC; Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):352-356. PubMed ID: 32483401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of zolpidem use among Iraq and Afghanistan veterans: A retrospective cohort analysis.
    Shayegani R; Song K; Amuan ME; Jaramillo CA; Eapen BC; Pugh MJ
    PLoS One; 2018; 13(1):e0190022. PubMed ID: 29360821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA; Roth T
    J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem prescribing and adverse drug reactions in hospitalized general medicine patients at a Veterans Affairs hospital.
    Mahoney JE; Webb MJ; Gray SL
    Am J Geriatr Pharmacother; 2004 Mar; 2(1):66-74. PubMed ID: 15555480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High usage of zolpidem and zopiclone. Cross-sectional study using claims data].
    Hoffmann F; Pfannkuche M; Glaeske G
    Nervenarzt; 2008 Jan; 79(1):67-72. PubMed ID: 17457554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater incidence of depression with hypnotic use than with placebo.
    Kripke DF
    BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescriptions for Bedtime Sedatives After the Introduction of a General Admission Order Set at an Academic Health Center: The Potential and Pitfalls of Order Sets.
    Kara A; Isaacs AN; Nisly SA
    J Patient Saf; 2017 Dec; 13(4):232-236. PubMed ID: 25719816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
    Salvà P; Costa J
    Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.